Markus Warmuth

Markus Warmuth is an experienced leader in the biotechnology and pharmaceutical sectors, currently serving as a Member of the Board of Directors at Ventus Therapeutics and Chief Executive Officer at Monte Rosa Therapeutics since September 2019. In addition, Markus holds the position of Venture Partner at Versant Ventures and has previously operated as an Independent Board Member at IMV Inc. and Relay Therapeutics. With a rich background that includes the role of President and CEO at H3 Biomedicine and Executive Director at Novartis Institutes for BioMedical Research, Markus has significant expertise in oncology and drug discovery, reinforced by a medical degree from Ludwig-Maximilians-Universität München.